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Running headline: Metabolism of 2-nitrobenzanthrone and 3-nitrobenzanthrone by 25 
hepatic microsomes 26 
 27 
OBJECTIVES: 2-Nitrobenzanthrone (2-NBA) has recently been detected in ambient 28 
air particulate matter. Its isomer 3-nitrobenzanthrone (3-NBA) is a potent mutagen 29 
and suspected human carcinogen identified in diesel exhaust. Understanding which 30 
enzymes are involved in metabolism of these toxicants is important in the 31 
assessment of individual susceptibility. Here, metabolism of 2-NBA and 3-NBA by rat 32 
and mouse hepatic microsomes containing cytochromes P450 (CYPs), their 33 
reductase (NADPH:CYP reductase), and NADH:cytochrome b5 reductase was 34 
investigated under anaerobic and aerobic conditions. In addition, using the same 35 
microsomal systems, 2-NBA and 3-NBA were evaluated to be enzymatically 36 
activated under anaerobic conditions to species generating 2-NBA- and 3-NBA-37 
derived DNA adducts. 38 
METHODS: High performance liquid chromatography (HPLC) with ultraviolet (UV) 39 
detection was employed for the separation and characterization of 2-NBA and 3-NBA 40 
metabolites formed by hepatic microsomes of rats and mice under the anaerobic and 41 
aerobic conditions. Microsomal systems isolated from the liver of the control 42 
(untreated) rats and rats pretreated with Sudan I, β-naphthoflavone (β-NF), 43 
phenobarbital (PB), ethanol and pregnenolon 16α-carbonitrile (PCN), the inducers of 44 
cytochromes P450 (CYP) 1A1, 1A1/2, 2B, 2E1 and 3A, respectively, were used in 45 
this study. Microsomes of mouse models, a control mouse line (wild-type, WT) and 46 
Hepatic Cytochrome P450 Reductase Null (HRN) mice with deleted gene of 47 
NADPH:CYP reductase in the liver, thus absenting this enzyme in their livers, were 48 
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also employed. To detect and quantify the 2-NBA- and 3-NBA-derived DNA adducts, 49 
the 32P postlabeling technique was used. 50 
RESULTS: Both reductive metabolite of 3-NBA, 3-aminobenzanthrone (3-ABA), 51 
found to be formed predominantly under the anaerobic conditions, and two 3-NBA 52 
oxidative metabolites, whose structures have not yet been investigated, were formed 53 
by several microsomal systems used in the study. Whereas a 3-NBA reductive 54 
metabolite, 3-ABA, was found only in the microsomal systems of control rats, the rats 55 
treated with β-NF and PB, and microsomes of WT and HRN mice, all hepatic 56 
microsomes tested in the study were capable of activating this carcinogen under the 57 
reductive conditions to form DNA adducts. A stability of a reactive intermediate of 3-58 
NBA, N-hydroxy-3-aminobenzanthrone that is formed during 3-NBA reduction to 3-59 
ABA, to form nitrenium (and/or carbenium) ions binding to DNA in individual 60 
microsomes as well as binding of these ions to proteins of these microsomes, might 61 
be the reasons explaining this phenomenon. In contrast to 3-NBA, its isomer 2-NBA 62 
was not metabolized by any of the used enzymatic systems both under the anaerobic 63 
and aerobic conditions.  Likewise, no DNA adducts were detectable after reaction of 64 
2-NBA in these systems with DNA. 65 
CONCLUSIONS: The results found in this study, the first report on the metabolism of 66 
2-NBA and 3-NBA by rat and mouse hepatic microsomes demonstrate that  3-NBA, 67 
in contrast to 2-NBA, is reductively activated to form 3-NBA-derived DNA adducts by 68 
these enzymatic systems. NADPH:CYP reductase can be responsible for formation 69 
of these DNA adducts in rat livers, while NADH:cytochrome b5 reductase can 70 
contribute to this process in livers of HRN mice. 71 
 72 
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ABBREVIATIONS & UNITS 77 
3-ABA – 3-aminobenzanthrone 78 
2-ABA – 2-aminobenzanthrone 79 
β-NF – β-naphthoflavone 80 
CYP - cytochrome P450 81 
dA-N6-3-ABA - 2-(2’-deoxyadenosin-N6-yl)-3-aminobenzanthrone 82 
dG-N2-3-ABA - N-(2’-deoxyguanosin-N2-yl)-3-aminobenzanthrone 83 
dG-C8-N-3-ABA - N-(2’-deoxyguanosin-8-yl)-3-aminobenzanthrone 84 
DMSO - dimethyl sulfoxide 85 
HPLC – high performance liquid chromatography  86 
HRN mice - Hepatic cytochrome P450 reductase null mice 87 
N-OH-2-ABA  -  N-hydroxy-2-aminobenzanthrone 88 
N-OH-3-ABA  -  N-hydroxy-3-aminobenzanthrone 89 
NADPH - nicotinamidadeninedinucleotide phosphate (reduced) 90 
2-NBA – 2-nitrobenzanthrone 91 
3-NBA – 3-nitrobenzanthrone 92 
NQO1 - NAD(P)H:quinone oxidoreductase 1 93 
PB – phenobarbital 94 
PCN - pregnenolon 16α-carbonitrile  95 
r.t. – retention time 96 
RAL - relative adduct labeling 97 
TLC - thin-layer chromatography 98 
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UV – ultraviolet 99 
WT – wild-type 100 
 101 
INTRODUCTION 102 
The increased lung cancer risk after exposure to the environmental pollutants 103 
nitro-polycyclic aromatic hydrocarbons and their detection in the lungs of non-104 
smokers with lung cancer has led to considerable interest in assessing their potential 105 
cancer risk (IARC, 1989; Vineis and Husgafvel-Pursiainen, 2005).  106 
The nitroaromatic 3-nitrobenzanthrone (3-nitro-7H-benz[de]anthracen-7-one, 3-107 
NBA, Figure 1) occurs in diesel exhaust and in airborne particulate matter (Enya et 108 
al., 1997, Seidel et al., 2002, Arlt, 2005, Nagy et al., 2005). 3-NBA exhibits extremely 109 
high mutagenic activity (Enya et al., 1997, Arlt, 2005) and is also a genotoxic 110 
carcinogen causing lung tumors in rats (Enya et al., 1997, Nagy et al., 2005). The 111 
predominant DNA adducts formed by 3-NBA after its metabolic activation by 112 
reduction of the nitro group (Arlt et al., 2003, 2005, Stiborova et al., 2006, 2008) are 113 
2-(2’-deoxyguanosin-N2-yl)-3-aminobenzanthrone and N-(2’-deoxyguanosin-8-yl)-3-114 
aminobenzanthrone (Arlt et al. 2004a, 2004b, 2006, Bieler et al., 2005; Vom Brocke, 115 
et al., 2009) and these are most probably responsible for the G to T transversion 116 
mutations induced by 3-NBA in Muta Mouse (Arlt et al., 2004c) and in TP53 using 117 
human TP53 knock-in (Hupki) murine embryonic fibroblasts (Vom Brocke, et al., 118 
2009). The metabolic activation of 3-NBA is mediated primarily by cytosolic 119 
NAD(P)H:quinone oxidoreductase 1 (NQO1), while N,O-acetyltransferases (NATs) 120 
and sulfotransferases (SULTs) are the major activating phase II enzymes (Arlt et al., 121 
2005, Stiborova et al., 2006, 2008) (Figure 1).  122 
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2-Nitrobenzanthrone (2-NBA), an isomer of 3-NBA, has been detected in ambient 123 
air particulate matter (Phousongphouang and Arey, 2003). Using a semiempirical 124 
quantum mechanical approach recent studies indicated small differences between 2-125 
NBA and 3-NBA in the reduction potential and the geometry of the nitro group 126 
attached to the benzanthrone skeleton (Takamura-Enya et al., 2006, Arlt et al., 2007; 127 
Reynisson et al., 2008, Nagy et al., 2007). Only differences in hydrophobicity were 128 
observed between these NBA isomers, indicating that penetration through cell 129 
membranes seems not to be identical for both compounds (Takamura-Enya et al., 130 
2006, Arlt et al., 2007, Stiborova et al., 2010b). The mutagenic and genotoxic 131 
potential of 2-NBA is, however, much lower than that of 3-NBA (Takamura-Enya et 132 
al., 2006, Arlt et al., 2007). Although 2-NBA has been shown to be genotoxic in vitro 133 
(Arlt et al., 2007, Nagy et al., 2007), lack of genotoxicity in vivo in rats (e.g. DNA 134 
adduct formation) was reported (Arlt et al., 2007). Nevertheless, its higher abundance 135 
than 3-NBA in ambient air urges further investigation to assess its potential hazard to 136 
human health. 137 
Recently, we have compared the efficiencies of human enzymatic systems such 138 
as hepatic cytosols and microsomes, NAD(P)H:quinone oxidoreductase 1 (NQO1), 139 
xanthine oxidase, NADPH:CYP reductase, N,O-acetyltransferases and 140 
sulfotransferases) and human primary hepatocytes to activate 2-NBA and its isomer 141 
3-NBA to species forming DNA adducts (Stiborova et al., 2010b). We have found that 142 
in contrast to 3-NBA, 2-NBA was not metabolized at detectable levels by the tested 143 
human enzymatic systems and enzymes expressed in human hepatocytes and no 144 
DNA adducts were generated by 2-NBA. Therefore, we have also concluded that 2-145 
NBA seems to possess a relatively lower risk to humans than 3-NBA (Stiborova et 146 
al., 2010b). 147 
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The aim of the present study was to investigate whether both studied 148 
environmental pollutants can be metabolized by other enzymatic systems, namely by 149 
hepatic microsomes of two animal models, rat and mice. Both reductive metabolism 150 
carried out under the anaerobic conditions and oxidative (aerobic) metabolism were 151 
examined. In addition, using the same microsomal systems, 2-NBA and 3-NBA were 152 
evaluated to be enzymatically activated under the anaerobic conditions to species 153 
generating 2-NBA- and 3-NBA-derived DNA adducts. 154 
 155 
MATERIAL AND METHODS 156 
Chemicals and enzymes. Microsomes from rat livers were isolated and 157 
characterized for CYP activities as described (Stiborova et al., 2010a, 2011). 158 
NADPH, calf thymus DNA and dimethylsulfoxide (DMSO) were obtained from Sigma 159 
Chemical Co (St Louis, MO, USA), Enzymes and chemicals for the 32P-postlabeling 160 
assay were obtained from sources described (Arlt et al., 2004a, 2004b, 2004c, 161 
Phillips, and Arlt, 2007). All these and other chemicals were reagent grade or better. 162 
Synthesis of 2-NBA, 3-NBA, 3-ABA and N-hydroxy-3-aminobenzanthrone (N-OH-163 
3-ABA). 2-NBA was synthesized as reported (Suzuki et al., 1997). 3-NBA, 3-ABA and 164 
N-OH-3-ABA were synthesized as described (Arlt et al., 2003, 2004b, Osborne e al., 165 
2005). Their authenticity was confirmed by UV spectroscopy, electrospray mass 166 
spectrometry and high field 1H NMR spectroscopy. Their purity was analyzed using 167 
HPLC, being >99.9% based on this method (Arlt et al., 2007).  168 
Preparation of microsomes and assays. The study was conducted in accordance 169 
with the Regulations for the Care and Use of Laboratory Animals (311/1997, Ministry 170 
of Agriculture, Czech Republic), which complies with the Declaration of Helsinki. 171 
Microsomes from livers of ten male untreated Wistar rats and those of ten male rats 172 
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pre-treated with Sudan I, β-naphthoflavone (β-NF), phenobarbital (PB), ethanol and 173 
pregnenolone-16α-carbonitrile (PCN) were prepared by the procedure described 174 
previously (Stiborova et al., 2003, 2011, Naiman et al., 2010). Protein concentrations 175 
in the microsomal fractions were assessed using the bicinchoninic acid protein assay 176 
with the bovine serum albumin as a standard (Weichelman et al., 1988). The 177 
concentration of CYP was estimated according to Omura and Sato (Omura and Sato, 178 
1964) based on absorption of the complex of reduced CYP with carbon monoxide. 179 
Hepatic microsomes of control (uninduced) rats and rats induced with Sudan I, β-NF, 180 
phenolbarbital (PB), ethanol and PCN contained 0.6, 1.8, 1.3, 2.7, 1.8 and 1.6 nmol 181 
CYP/mg protein, respectively. The activity of NADPH:CYP reductase in rat hepatic 182 
microsomes was measured according to Sottocasa et al. (1967) using cytochrome c 183 
as substrate (i.e., as NADPH:cytochrome c reductase). NADPH:CYP reductase 184 
activities in hepatic microsomes of control (uninduced) rats and rats induced with 185 
Sudan I, β-NF, PB, ethanol and PCN were 0.210, 0.202, 0.199, 0.325, 0.201 and 186 
0.290 µmol/min/mg protein, respectively.  187 
Mouse hepatic microsomes from livers of four HRN (Hepatic Cytochrome P450 188 
Reductase Null) (Porlox/lox + CreALB) mice (Henderson et al., 2003) and four wild-type 189 
(WT) mice were isolated using the same procedures as described above. Hepatic 190 
microsomes of WT and HRN mice contained 0.3 and 0.4 nmol CYP/mg protein, 191 
respectively. NADPH:CYP reductase activity in hepatic microsomes of WT mice was 192 
0.120 µmol/min/mg protein, but it was not detectable in microsomes of HRN mice.  193 
Incubations. Incubation mixtures used for activation of 2-NBA and 3-NBA 194 
metabolism by rat and mouse hepatic microsomes to species forming DNA adducts 195 
were carried out as described previously (Arlt et al., 2003, Stiborova et al., 2010b). 196 
Briefly, the deaerated and argon-purged incubation mixtures, in a final volume of 750 197 
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µl, consisted of 50 mM Tris/HCl buffer (pH 7.4), 1 mM NADPH, rat or mouse hepatic 198 
microsomes (1 mg of protein), 0.5 mg of calf thymus DNA and 100 µM 2-NBA or 3-199 
NBA (dissolved in 12.5 µl dimethyl sulfoxide - DMSO). This relatively high 200 
concentration of DMSO in reaction mixtures, which might inhibit activities of some 201 
CYPs, was necessary to be used, because of the very low solubility of 2-NBA or 3-202 
NBA. The same volume of DMSO was added into the control sample (without 2-NBA 203 
or 3-NBA). In the case of mouse hepatic microsomes, incubation mixtures of the 204 
same composition, but containing of 1 mM NADH instead of 1 mM NADPH, were 205 
used. The reaction was initiated by adding 2-NBA or 3-NBA. Incubations were carried 206 
out at 37°C for 2 hr; 3-NBA-derived DNA adduct formation was found to be linear up 207 
to 3 hr (Arlt et al., 2003). Control incubations were carried out (i) without activating 208 
system (microsomes), (ii) without NADPH, (iii) without DNA or (iv) without 3-NBA or 209 
2-NBA. After the incubation and extraction with ethyl acetate, DNA was isolated from 210 
the residual water phase by the phenol/chloroform extraction method as described 211 
(Arlt et al., 2003). 212 
Incubations mixtures used to study 2-NBA and 3-NBA metabolism by rat and 213 
mouse hepatic microsomes, containing final volume of 500 µl, consisted of 50 mM 214 
Tris/HCl buffer (pH 7.4), 1 mM NADPH, 0.5 mg of microsomal protein and 50 µM 2-215 
NBA or 3-NBA (dissolved in DMSO). The reaction was initiated by adding 2-NBA or 216 
3-NBA. Reaction mixtures were incubated at 37°C for 60 min both under the aerobic 217 
conditions (in open tubes) and under the anaerobic conditions that are described 218 
above (see incubation conditions used to study activation of 2-NBA and 3-NBA to 219 
form DNA adducts). In control incubations NADPH was omitted from the mixtures. 220 
After incubation, the mixtures were extracted twice with ethyl acetate (2×1 ml) and 5 221 
µl of 1 mM phenacetine in methanol was added as an internal standard. The extracts 222 
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were evaporated to dryness; residues were dissolved in 30 µl of methanol, and 223 
subjected to reverse phase-HPLC to evaluate the amounts of 2-aminobenzanthrone 224 
(2-ABA) or 3-ABA formed.  225 
HPLC. HPLC was performed with a Dionex HPLC pump P580 with UV/VIS UVD 226 
170S/340S spectrophotometric detector set at 254 nm, and peaks were integrated 227 
with a ChromeleonTM 6.01 integrator (Stiborova et al., 2010b; Klejdus et al., 2005). 228 
The column used was a Nucleosil 100-5 C18 (Macherey-Nagel, Düren, Germany, 25 229 
cm × 4.6 mm, 5 µm), preceded by a C-18 guard column. Chromatography was under 230 
isocratic conditions of 70% methanol in water, with a flow rate of 0.6 ml/min. 231 
Recoveries of 2-NBA, 3-NBA and 3-ABA were around 95%. 3-ABA, 3-NBA and 2-232 
NBA were eluted with retention times (r.t.) of 7.8, 24.6 and 25.4 minutes, respectively 233 
(Figure 2)   234 
32P-Postlabeling analysis of DNA adducts. 32P-Postlabeling analysis using n-235 
butanol extraction, and thin layer chromatography (TLC) and HPLC were performed 236 
as described (Arlt et al, 2006, Stiborova et al., 2010b). Enrichment by n-butanol 237 
extraction has been shown to yield more adduct spots and a better recovery of 3-238 
NBA-derived DNA adducts than enrichment by nuclease P1 digestion (Arlt et al, 239 
2004a, 2004b, 2004c, 2006, Stiborova et al., 2006). The detection limit certain 240 
individual adducts was around 1 adduct per 1010 nucleotides. 3-NBA-derived DNA 241 
adducts were identified using standards of 2-(2’-deoxyadenosin-N6-yl)-3-242 
aminobenzanthrone-3’-phosphate, N-(2’-deoxyguanosin-N2-yl)-3-243 
aminobenzanthrone-3’-phosphate and N-(2’-deoxyguanosin-8-yl)-3-244 
aminobenzanthrone-3’-phosphate as described (Arlt et al, 2006, Stiborova et al., 245 
2010b).   246 
 247 
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RESULTS AND DISCUSSION 248 
Metabolism of 2-NBA and 3-NBA by rat and mouse hepatic microsomes. In initial 249 
experiments, 3-NBA was incubated with rat hepatic microsomes in the presence of 250 
NADPH, a cofactor of CYP- and NADPH:CYP reductase-mediated reactions, under 251 
the anaerobic conditions. Using HPLC with UV detection, one major 3-NBA reduction 252 
product (see Figure 2) was found. Using co-chromatography with synthetic 253 
standards, this peak was identified to be the 3-NBA reduction product, namely 3-ABA 254 
(Figure 2). No 3-ABA was detectable when NADPH was omitted from the incubation 255 
mixtures. This finding suggest that either NADPH:CYP reductase or CYP enzymes 256 
might be responsible for reduction of 3-NBA to 3-ABA. A time-dependent decrease in 257 
3-NBA in incubation mixture corresponded to an increase in 3-ABA formation (data 258 
not shown). No N-OH-3-ABA was detectable by HPLC, although it should be formed 259 
during 3-NBA reduction to 3-ABA and as a reactive intermediate binding to DNA (Arlt 260 
et al., 2003, 2005). Because of the reactivity of this intermediate, it is easily 261 
converted to the nitrenium and/or carbenium ion (Figure 1), which may be scavenged 262 
by the microsomal proteins present in the incubation mixtures.   263 
In the case of a rat animal model, besides hepatic microsomes of control 264 
(untreated) rats, we have also used hepatic microsomes of rats treated with several 265 
CYP inducers such as Sudan I and β-NF, which are inducers of CYP1A1/2, PB, 266 
which is an inducer of CYP2B, ethanol, which increases the levels of CYP2E1 and 267 
PCN, which induces CYP3A. Under the anaerobic conditions, hepatic microsomes of 268 
control (untreated) rats and microsomes of rats treated with β-NF and PB were 269 
capable of reducing 3-NBA to 3-ABA, having almost the same efficiencies to form 270 
this 3-NBA metabolite (Table 1). Surprisingly, hepatic microsomes of rats treated with 271 
β-NF reduced 3-NBA even under the aerobic conditions (Table 1). This unexpected 272 
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result remains to be explained. In contrast to these results, the final reduction 273 
metabolite of 3-NBA, 3-ABA, was not detectable in other microsomes tested in this 274 
study (Table 1). Amounts of 3-ABA formed by individual rat hepatic microsomes did 275 
not correspond either to specific contents of CYP or to activities of NADPH:CYP 276 
reductase in these microsomes. This finding suggests that amounts of 3-ABA 277 
detectable in microsomal systems does not depend only on the activities of both 278 
types of enzymes, but also on other, still unknown, factors. A stability of a reactive 279 
intermediate of 3-NBA, N-OH-3-ABA that is formed during 3-NBA reduction to 3-ABA 280 
to form nitrenium (and/or carbenium) ions binding to DNA in individual microsomes, 281 
as well as binding of these ions to microsomal proteins, might be the reasons 282 
explaining this phenomenon. These results also indicate that the determination of 283 
amounts of the final reductive metabolite of 3-NBA, 3-ABA, seems not to be a 284 
suitable marker which should be used to evaluate efficiencies of enzymatic systems 285 
to reduce 3-NBA, the crucial reaction leading to 3-NBA-derived DNA adducts (Figure 286 
1).  287 
Hepatic microsomes of WT and HRN mice were also able to reduce 3-NBA to 3-288 
ABA, both under the anaerobic and aerobic conditions. Lower amounts of 3-ABA was 289 
formed by hepatic microsomes of HRN mice, but these microsomes were more 290 
effective in this reaction under the aerobic than the anaerobic conditions (Table 1). 291 
Under the aerobic conditions, hepatic microsomes of control rats and rats 292 
pretreated with PB, ethanol and PCN were also capable of oxidizing 3-NBA. Using 293 
HPLC with UV detection, up to two 3-NBA oxidation products, eluted with the 294 
retention times (r.t.) of 13 and 18 min, were found (data not shown). Hepatic 295 
microsomes of control rats generated both these metabolites, whereas microsomes 296 
of rats treated with PB formed only the metabolite eluting at 13 min and microsomes 297 
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of rats pretreated with ethanol and PCN formed the metabolite eluting at 18 min.  298 
Structures of these metabolites remain to be characterized. No such metabolites 299 
were generated by hepatic microsomes of the rats treated with other CYP inducers 300 
and microsomes of both mouse models. 301 
In contrast to 3-NBA that is reduced by several microsomal systems to 3-ABA, 302 
no 2-aminobenzanthrone (2-ABA) was found to be generated from 2-NBA by all 303 
hepatic microsomes used in the experiments (see Figure 2). Likewise, no oxidation 304 
product peaks were detectable by HPLC employed to separate the 2-NBA 305 
metabolites.  306 
Activation of 2-NBA and 3-NBA to species forming DNA adducts. In initial 307 
experiments, we compared the DNA adduct formation by 2-NBA and 3-NBA using 308 
hepatic microsomal systems under standardized experimental conditions, in the 309 
presence of NADPH, a cofactor of microsomal enzymes (NADPH:CYP reductase 310 
and CYPs). The same rat and mouse hepatic microsomes that were used to study 311 
metabolism of 2-NBA and 3-NBA were utilized. The formation of DNA adducts was 312 
analyzed using the butanol extraction version of the 32P-postlabeling method.  313 
In accordance with our previous in-vitro studies (Bieler et al., 1999, Arlt et al., 314 
2003, 2005, Stiborova et al., 2006, 2008), the DNA adduct pattern generated from 3-315 
NBA by these enzymatic systems, consisted of a cluster of at least five adducts 316 
(spots indicated with arrows in Figure 3) essentially identical to those found 317 
previously in vivo in rats and mice treated with this carcinogen (Arlt et al., 2003, 318 
2005, Bieler et al., 2005, 2007). Co-chromatographic analysis of individual spots on 319 
HPLC confirmed that adduct spots are derived from 3-NBA by nitroreduction (data 320 
not shown). Three of these adducts were identified as 2-(2’-deoxyadenosin-N6-yl)-3-321 
aminobenzanthrone (dA-N6-3-ABA, spot 1), 2-(2’-deoxyguanosin-N2-yl)-3-322 
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aminobenzanthrone (dG-N2-3-ABA, spot 3) and N-(2’-deoxyguanosin-8-yl)-3-323 
aminobenzanthrone (dG-C8-N-3-ABA, spots 4,5) (see Fig. 3). TLC autoradiograms of 324 
32P-labeled DNA from control incubations carried out in parallel without activation 325 
systems, without DNA, or without 3-NBA or without NADPH, a cofactor of microsomal 326 
enzymes (CYPs and NADPH:CYP reductase), were devoid of adduct spots in the 327 
region of interest (data not shown). These results indicate that both CYPs and 328 
NADPH:CYP reductase might be responsible for the reductive activation of 3-NBA 329 
leading to the formation of these DNA adducts.  330 
In the species comparison, microsomes from rats were more efficient to activate 331 
3-NBA than those of mice, mainly the microsomes of HRN mice. The efficiency of rat 332 
and mouse hepatic microsomes to activate 3-NBA corresponded to the NADPH:CYP 333 
reductase activity (Table 2). Incubations of 3-NBA and DNA with hepatic microsomes 334 
of rats pretreated with inducers of NADPH:CYP reductase, PCN and PB, led to a 4- 335 
and 3-fold increase, respectively, in the formation of 3-NBA-DNA adducts, while 336 
lower activities of this enzyme in mouse hepatic microsomes resulted in a decrease 337 
in levels of 3-NBA-DNA adducts (Table 2). These results suggest that NADPH:CYP 338 
reductase might be the major enzyme responsible for reductive activation of 3-NBA 339 
to form DNA adducts in hepatic microsomes (Arlt et al., 2003). Interestingly, 3-NBA-340 
derived DNA adducts were also formed in hepatic microsomes of HRN mice, where 341 
no activity of NADPH:CYP reductase was detectable. Therefore, another enzyme 342 
should be responsible for 3-NBA activation in these microsomes. Using NADH, a 343 
cofactor of NADH:cytochrome b5 reductase in incubation mixtures containing hepatic 344 
microsomes of HRN mice, higher levels of 3-NBA-derived DNA adducts were found 345 
(Table 3). Hence, NADH:cytochrome b5 reductase can substitute the NADPH:CYP 346 
reductase in reductive activation of 3-NBA in hepatic microsomes of HRN mice.  347 
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In contrast to the results found with 3-NBA, no 2-NBA-derived DNA adducts were 348 
detected under the same experimental conditions with any of the hepatic microsomes 349 
used in the experiments (Figure 2). This finding corresponds fully with the lack of 2-350 
NBA reduction in these hepatic microsomal enzymatic systems (see Figure 2). 351 
 352 
CONCLUSIONS 353 
The results of this study show that in contrast to 3-NBA, 2-NBA is not a substrate 354 
of the enzymes present in the rat and mouse hepatic microsomal systems tested in 355 
our experiments. Using the 32P-postlabeling assay, which is in principle sensitive 356 
enough to detect DNA adduct levels as low as 1 adduct per 1010 normal nucleotides 357 
(Phillips and Arlt, 2007), we were unable to detect 2-NBA-derived DNA adducts 358 
catalyzed by any of the microsomal enzymatic systems utilized. Our results 359 
correspond to data published previously showing that 2-NBA-derived DNA adducts 360 
were not detected both in vitro, in several human enzymatic systems (Stiborova et al, 361 
2010b) and in Wistar rats treated with 2-NBA in vivo (Arlt et al., 2007). Only after the 362 
administration of the reactive N-hydroxylated intermediate N-hydroxy-2-363 
aminobenzanthrone (N-OH-2-ABA), 2-NBA-derived DNA adducts were detectable in 364 
several rat organs such as lung, liver, kidney, colon and pancreas (Arlt et al., 2007).  365 
In the case of 3-NBA, this carcinogen is reduced by rat and mouse hepatic 366 
microsomes to species forming 3-NBA-derived DNA adducts. NADPH:CYP 367 
reductase seems to be the major enzyme reductively activating 3-NBA in rat and/or 368 
mouse liver microsomes. However, when this enzyme is absenting in the 369 
microsomes, like it is in hepatic microsomes of HRN mice, NADH:cytochrome b5 can 370 
substitute NADPH:CYP reductase in this activation reaction. The results found in the 371 
experiments determining the amounts of the final reductive metabolite of 3-NBA, 3-372 
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ABA, and levels of 3-NBA-derived DNA adducts strongly suggest that determination 373 
of the levels of these DNA adducts are a more suitable method to evaluate the 374 
enzymes responsible for reductive activation of this carcinogen than that of amounts 375 
of formed 3-ABA. 376 
Finally, the present study has increased our knowledge on the potential of rat and 377 
mouse hepatic microsomal enzymatic systems to reductively activate the two NBA 378 
urban air pollutants, 2-NBA and 3-NBA. In accordance with previous data our results 379 
indicate that 3-NBA is a potent genotoxin and carcinogen (Arlt et al., 2003, 2005, 380 
Bieler et al., 2007, Stiborova et al., 2006, 2008, 2010b), supporting our efforts in 381 
investigating the mechanisms of 3-NBA carcinogenicity.  382 
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Table 1. Amounts of 3-ABA formed from 3-NBA during its incubation with different rat 519 
or mouse hepatic microsomes 520 
 521 
 










5.2 ± 0.1 
 Aerobic 0 
rats treated with Sudan I  Anaerobic 0 
 Aerobic 0 
rats treated with β-NF  Anaerobic 4.6 ± 0.5 
 Aerobic 4.6 ± 0.1 
rats treated with PB  Anaerobic 5.8 ± 0.9 
 Aerobic 0 
rats treated with ethanol  Anaerobic 0 
 Aerobic 0 
rats treated with PCN  Anaerobic 0 
 









3.1 ± 0.8 
3.6 ± 0.3 
1.5 ± 0.2 
2.8 ± 0.3 
 522 
Experimental conditions are described in Material and methods. NADPH was used in 523 
all incubations mixtures. Values in the table are averages and standard deviations of 524 






Table 2. Total levels of DNA adducts formed after activation of 3-NBA by different rat 530 
or mouse hepatic microsomes in the presence of NADPH 531 
 532 
 





Total levels of 3-NBA-
DNA adducts 
(RAL/108 nucleotides)  
control rats  Anaerobic 4.2 ± 0.4 
rats treated with β-NF  Anaerobic 3.4 ± 0.3 
rats treated with PB  Anaerobic 12.1 ± 1.0 
rats treated with ethanol  Anaerobic 3.9 ± 0.4 
rats treated with PCN  Anaerobic 15.9 ± 1.3 
control mice (WT mice) Anaerobic 0.66 ± 0.05 
HRN mice  Anaerobic 0.54 ± 0.05 
 533 
Experimental conditions are described in Material and methods. 1 mM NADPH was 534 
used in all incubations mixtures. Values in the table are averages and standard 535 







Table 3. Total levels of DNA adducts formed after activation of 3-NBA by mouse 542 
hepatic microsomes in the presence of NADH 543 
 544 
 





Total levels of 3-NBA-
DNA adducts 
(RAL/108 nucleotides)  
control mice (WT mice) Anaerobic 0.25 ± 0.03 
HRN mice  Anaerobic 0.91 ± 0.08 
 545 
Experimental conditions are described in Material and methods. 1 mM NADH was 546 
used in incubations mixtures. Values in the table are averages and standard 547 
deviations of three determinations. RAL – relative adduct labeling. 548 
 549 
 550 












Figure 1. Pathways of metabolic activation and DNA adduct formation of 3-562 
nitrobenzanthrone and 3-aminobenzanthrone. See text for details. 3-NBA, 3-563 
nitrobenzanthrone; 3-ABA, 3-aminobenzanthrone; NQO1, NAD(P)H:quinone 564 
oxidoreductase; NAT, N,O-acetyltransferases; SULT, sulfotransferase; CYP, 565 
cytochrome P450; HRP, horseradish peroxidase; LPO, lactoperoxidase; MPO, 566 
myeloperoxidase; PHS-1, prostaglandin H synthase 1 (cyclooxygenase 1); POR, 567 
NADPH:CYP oxidoreductase; R = -COCH3 or -SO3H; dA-N6-ABA, 2-(2’-568 
deoxyadenosin-N6-yl)-3-aminobenzanthrone; dG-N2-ABA, N-(2’-deoxyguanosin-N2-569 
yl)-3-aminobenzanthrone; dG-C8-N-ABA, N-(2’-deoxyguanosin-8-yl)-3-570 
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Figure 2. HPLC chromatographs of 2-NBA (A) and 3-NBA (B) metabolites produced 581 
by human NQO1 under the anaerobic conditions. Experimental conditions are 582 























































































Figure 3. Autoradiographic profiles of DNA adducts generated by 100 µM 2-NBA (A) 595 
and 100 µM 3-NBA (B) after activation with hepatic microsomes of rats pretreated 596 
with PCN. Experimental conditions are described in Material and methods. Spot 1, 597 
dA-N6-3-ABA, spot 3, dG-N2-3-ABA, and spots 4,5, dG-C8-N-3-ABA. 598 
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